JP2012533554A - 小児のためのオロパタジン経鼻噴霧剤レジメン - Google Patents

小児のためのオロパタジン経鼻噴霧剤レジメン Download PDF

Info

Publication number
JP2012533554A
JP2012533554A JP2012520770A JP2012520770A JP2012533554A JP 2012533554 A JP2012533554 A JP 2012533554A JP 2012520770 A JP2012520770 A JP 2012520770A JP 2012520770 A JP2012520770 A JP 2012520770A JP 2012533554 A JP2012533554 A JP 2012533554A
Authority
JP
Japan
Prior art keywords
amount
olopatadine
period
composition
phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012520770A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012533554A5 (enExample
Inventor
マイケル ジー． ウォール，
Original Assignee
アルコン リサーチ， リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルコン リサーチ， リミテッド filed Critical アルコン リサーチ， リミテッド
Publication of JP2012533554A publication Critical patent/JP2012533554A/ja
Publication of JP2012533554A5 publication Critical patent/JP2012533554A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2012520770A 2009-07-17 2010-07-15 小児のためのオロパタジン経鼻噴霧剤レジメン Pending JP2012533554A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22646909P 2009-07-17 2009-07-17
US61/226,469 2009-07-17
PCT/US2010/042085 WO2011008923A2 (en) 2009-07-17 2010-07-15 Olopatadine nasal spray regimen for children

Publications (2)

Publication Number Publication Date
JP2012533554A true JP2012533554A (ja) 2012-12-27
JP2012533554A5 JP2012533554A5 (enExample) 2013-08-08

Family

ID=42664656

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012520770A Pending JP2012533554A (ja) 2009-07-17 2010-07-15 小児のためのオロパタジン経鼻噴霧剤レジメン

Country Status (17)

Country Link
US (2) US20110011392A1 (enExample)
EP (1) EP2453872B1 (enExample)
JP (1) JP2012533554A (enExample)
KR (1) KR20120046215A (enExample)
CN (2) CN102470099A (enExample)
AU (1) AU2010273347B2 (enExample)
BR (1) BR112012001169A2 (enExample)
CA (1) CA2768006A1 (enExample)
DK (1) DK2453872T3 (enExample)
ES (1) ES2432502T3 (enExample)
HR (1) HRP20130946T1 (enExample)
MX (1) MX2012000539A (enExample)
PL (1) PL2453872T3 (enExample)
PT (1) PT2453872E (enExample)
SI (1) SI2453872T1 (enExample)
WO (1) WO2011008923A2 (enExample)
ZA (1) ZA201109320B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9370483B2 (en) 2013-09-13 2016-06-21 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US9937189B2 (en) 2013-09-13 2018-04-10 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US10548907B2 (en) 2013-10-04 2020-02-04 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10653661B2 (en) 2013-10-04 2020-05-19 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10758550B2 (en) 2013-10-04 2020-09-01 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
RU2686670C2 (ru) 2013-10-04 2019-04-30 Гленмарк Спешиалити С.А. Лечение аллергического ринита с использованием комбинации мометазона и олопатадина
US10016443B2 (en) 2013-10-04 2018-07-10 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US11679210B2 (en) 2014-10-03 2023-06-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN107569454B (zh) * 2017-09-29 2018-05-04 深圳大佛药业股份有限公司 一种盐酸奥洛他定鼻喷雾剂及其制备方法
MX2020008741A (es) 2018-02-23 2020-09-28 Glenmark Specialty Sa Tratamiento de la rinitis alergica en sujetos pediatricos con una combinacion de mometasona y olopatadina.
US12303635B2 (en) 2018-04-16 2025-05-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN109806224B (zh) * 2019-03-15 2021-05-28 江苏长泰药业有限公司 一种奥洛他定组合物及其制备方法
WO2021158736A1 (en) * 2020-02-06 2021-08-12 Corbett Lair, Inc. Method, apparatus and kit for treating chronic and long-term nasal congestion
WO2025137749A1 (pt) * 2023-12-27 2025-07-03 Eurofarma Laboratórios S.A. Processo de solubilização de olopatadina e seu uso

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003506396A (ja) * 1999-08-07 2003-02-18 グラクソ・ウエルカム株式会社 水性経鼻製剤
JP2004503489A (ja) * 2000-06-16 2004-02-05 グラクソ　グループ　リミテッド 新規な水性抗炎症医薬製剤
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
JP2006517981A (ja) * 2003-02-17 2006-08-03 サン・ファーマシューティカル・インダストリーズ・リミテッド 低用量コルチコステロイド組成物
WO2008097220A1 (en) * 2007-02-07 2008-08-14 Alcon, Inc. Olopatadine formulations for topical nasal administration

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
SE8704767L (sv) * 1987-11-30 1989-05-31 Sigmund Johannes Loefstedt Ny metod foer administrering av laekemedel
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
US20040214754A1 (en) * 2001-10-03 2004-10-28 Ellis Edward J. Ophthalmic preparation containing glycomacropeptide
US20030004179A1 (en) * 2002-05-21 2003-01-02 Affrime Melton B Treating allergic and inflammatory conditions
AU2005309951B2 (en) * 2004-11-24 2011-07-07 Alcon, Inc. Method of delivering nasal spray

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
JP2003506396A (ja) * 1999-08-07 2003-02-18 グラクソ・ウエルカム株式会社 水性経鼻製剤
JP2004503489A (ja) * 2000-06-16 2004-02-05 グラクソ　グループ　リミテッド 新規な水性抗炎症医薬製剤
JP2006517981A (ja) * 2003-02-17 2006-08-03 サン・ファーマシューティカル・インダストリーズ・リミテッド 低用量コルチコステロイド組成物
WO2008097220A1 (en) * 2007-02-07 2008-08-14 Alcon, Inc. Olopatadine formulations for topical nasal administration

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6014028482; Ｎ．　Ｊ．　Ａｍａｒ　ｅｔ　ａｌ．: Ｊ．　Ａｌｌｅｒｇｙ　Ｃｌｉｎ．　Ａｍｍｕｎｏｌ． ｖｏｌ．１２１，　Ｎｏ．２，　Ｓｕｐｐｌ．１, 2008, ｐ．Ｓ５０ *
JPN6014028483; Ｐ．　Ｈ．　Ｒａｔｎｅｒ　ｅｔ　ａｌ．: Ａｎｎａｌｓ．　ｏｆ　Ａｌｌｅｒｇｙ，　Ａｓｔｈｍａ　＆　Ｉｍｍｕｎｏｌｏｇｙ ｖｏｌ．９５, 2005, ｐ．４７４-４７９ *
JPN6015008393; 治療，　１９９６，　ｖｏｌ．７８，　増刊号，　ｐ．１２３９-１２４３ *

Also Published As

Publication number Publication date
BR112012001169A2 (pt) 2016-03-01
HRP20130946T1 (hr) 2013-11-08
AU2010273347B2 (en) 2015-04-30
PT2453872E (pt) 2013-10-30
KR20120046215A (ko) 2012-05-09
CN104173273A (zh) 2014-12-03
CA2768006A1 (en) 2011-01-20
DK2453872T3 (da) 2013-10-07
AU2010273347A1 (en) 2012-03-08
MX2012000539A (es) 2012-02-28
WO2011008923A3 (en) 2011-12-08
US20140007865A1 (en) 2014-01-09
PL2453872T3 (pl) 2013-12-31
ZA201109320B (en) 2013-03-27
EP2453872B1 (en) 2013-08-21
ES2432502T3 (es) 2013-12-03
EP2453872A2 (en) 2012-05-23
SI2453872T1 (sl) 2013-10-30
WO2011008923A2 (en) 2011-01-20
CN102470099A (zh) 2012-05-23
US20110011392A1 (en) 2011-01-20

Similar Documents

Publication Publication Date Title
JP2012533554A (ja) 小児のためのオロパタジン経鼻噴霧剤レジメン
JP4500045B2 (ja) 感冒の治療のための組成物
US9750754B2 (en) Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US10517880B2 (en) Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
KR20140009332A (ko) 고농도 올로파타딘 안과용 조성물
US7378082B1 (en) Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) Aqueous formulations of epinastine for treating allergic rhinitis
JP5149308B2 (ja) 局所的鼻腔投与のためのオロパタジンの製剤
JPH02196716A (ja) 薬学的溶液
WO2021202332A1 (en) Aqueous formulations containing povidone iodine for effective treatment and prevention of virus infections
RU2687551C2 (ru) Стабильная фармацевтическая композиция с фиксированной дозой, содержащая мометазон и олопатадин
EP2928302A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
HK1217090B (en) Olopatadine formulations for topical nasal administration

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130618

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130618

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140704

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141001

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150703